2BBBullish & Bearish
Alto Neuroscience, Inc. Common Stock (ANRO) trades on NYSE. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 40 out of 100.
Alto Neuroscience, Inc. Common Stock’s current 2BB score is 40 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 69 | High |
| Momentum | 81 | Strongly Improving |
| Financial strength | 18 | Very Weak |
| Quality | 80 | Very Strong |
| Risk | 39 | Low |
| Founded | 2019 |
| Employees | 68 |
| 52-week range | $3.02 – $29.70 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-05-13 | -0.8 | -0.5473 | $0.00 | $0.00 |
| 2026-03-16 | -0.58 | -0.5414 | $0.00 | $0.00 |